# Dual-target, High-dose TMS for PD Patients With FOG

> **NCT05625386** · NA · TERMINATED · sponsor: **Anhui Medical University** · enrollment: 64 (actual)

## Conditions studied

- Transcranial Magnetic Stimulation
- Freezing of Gait

## Interventions

- **DEVICE:** transcranial magnetic stimulation

## Key facts

- **NCT ID:** NCT05625386
- **Lead sponsor:** Anhui Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-12-22
- **Primary completion:** 2024-02-25
- **Final completion:** 2024-03-31
- **Target enrollment:** 64 (ACTUAL)
- **Why stopped:** The study was halted at the midpoint because the interim analysis demonstrated a large effect size of the DHT group compared with the SCT group (Cohen's d = 1.58).
- **Last updated:** 2025-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05625386

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05625386, "Dual-target, High-dose TMS for PD Patients With FOG". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05625386. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*